Carolinas Wealth Consulting’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Carolinas Wealth Consulting's EXAS Position: Q1 2024 in Review
Carolinas Wealth Consulting sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 18 shares — an estimated $1.32K sold.
Carolinas Wealth Consulting first reported a position in EXAS in Q2 2023 and held it in 3 quarters. The position peaked at $1.76K in Q2 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.
- Carolinas Wealth Consulting reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
- Carolinas Wealth Consulting sold 18 Exact Sciences shares in Q1 2024, an estimated $1.32K.
- Carolinas Wealth Consulting first reported a position in Exact Sciences in Q2 2023 and held it in 3 quarters.
- Carolinas Wealth Consulting's Exact Sciences position peaked at $1.76K in Q2 2023.
- 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.
Based on Carolinas Wealth Consulting's 13F filing for Q1 2024, filed 15 May 2024.